What are the benefits of using WIPO Standard ST.26 for sequence listings?
WIPO Standard ST.26 offers several benefits for sequence listings in patent applications:
- International Compatibility: It allows for a single, internationally acceptable sequence listing format.
- Language Neutrality: The format is language-neutral, facilitating use across different countries and regions.
- Standardization: It uses specified International Nucleotide Sequence Database Collaboration (INSDC) identifiers, ensuring consistency across applications.
- Efficiency: A single sequence listing can be prepared for use in multiple intellectual property offices of WIPO member states.
MPEP 2412 states: “As a result, a single sequence listing in compliance with WIPO Standard ST.26 can be prepared for use in the IPOs of WIPO member states.” This streamlines the application process for inventors and patent attorneys working on international patent applications.
To learn more:
Topics:
MPEP 2400 - Biotechnology,
MPEP 2412 - The Requirements For Patent Applications Containing Nucleotide Sequence And/Or Amino Acid Sequence Disclosures To Include A Sequence Listing In Xml File Format,
Patent Law,
Patent Procedure